Covert operations of uropathogenic Escherichia coli within the urinary tract
- PMID: 15569242
- PMCID: PMC2523259
- DOI: 10.1111/j.1600-0854.2004.00251.x
Covert operations of uropathogenic Escherichia coli within the urinary tract
Abstract
Entry into host cells is required for many bacterial pathogens to effectively disseminate within a host, avoid immune detection and cause disease. In recent years, many ostensibly extracellular bacteria have been shown to act as opportunistic intracellular pathogens. Among these are strains of uropathogenic Escherichia coli (UPEC), the primary causative agents of urinary tract infections (UTIs). UPEC are able to transiently invade, survive and multiply within the host cells and tissues constituting the urinary tract. Invasion of host cells by UPEC is promoted independently by distinct virulence factors, including cytotoxic necrotizing factor, Afa/Dr adhesins, and type 1 pili. Here we review the diverse mechanisms and consequences of host cell invasion by UPEC, focusing also on the impact of these processes on the persistence and recurrence of UTIs.
Figures




Similar articles
-
Type 1, P and S fimbriae, and afimbrial adhesin I are not essential for uropathogenic Escherichia coli to adhere to and invade bladder epithelial cells.FEMS Immunol Med Microbiol. 2002 Mar 25;33(1):23-6. doi: 10.1111/j.1574-695X.2002.tb00567.x. FEMS Immunol Med Microbiol. 2002. PMID: 11985964
-
Virulence factors of uropathogenic E. coli and their interaction with the host.Adv Microb Physiol. 2014;65:337-72. doi: 10.1016/bs.ampbs.2014.08.006. Epub 2014 Nov 4. Adv Microb Physiol. 2014. PMID: 25476769 Review.
-
Mechanisms and consequences of bladder cell invasion by uropathogenic Escherichia coli.Eur J Clin Invest. 2008 Oct;38 Suppl 2:2-11. doi: 10.1111/j.1365-2362.2008.01986.x. Epub 2008 Jul 8. Eur J Clin Invest. 2008. PMID: 18616559 Review.
-
Functional analysis of antigen 43 in uropathogenic Escherichia coli reveals a role in long-term persistence in the urinary tract.Infect Immun. 2007 Jul;75(7):3233-44. doi: 10.1128/IAI.01952-06. Epub 2007 Apr 9. Infect Immun. 2007. PMID: 17420234 Free PMC article.
-
Metabolic Requirements of Escherichia coli in Intracellular Bacterial Communities during Urinary Tract Infection Pathogenesis.mBio. 2016 Apr 12;7(2):e00104-16. doi: 10.1128/mBio.00104-16. mBio. 2016. PMID: 27073089 Free PMC article.
Cited by
-
Pleiotropic roles of uvrY on biofilm formation, motility and virulence in uropathogenic Escherichia coli CFT073.PLoS One. 2013;8(2):e55492. doi: 10.1371/journal.pone.0055492. Epub 2013 Feb 1. PLoS One. 2013. PMID: 23383333 Free PMC article.
-
Environmental phosphate differentially affects virulence phenotypes of uropathogenic Escherichia coli isolates causative of prostatitis.Virulence. 2015;6(6):608-17. doi: 10.1080/21505594.2015.1059561. Epub 2015 Jun 17. Virulence. 2015. PMID: 26083279 Free PMC article.
-
Role of Uropathogenic Escherichia coli Virulence Factors in Development of Urinary Tract Infection and Kidney Damage.Int J Nephrol. 2012;2012:681473. doi: 10.1155/2012/681473. Epub 2012 Mar 8. Int J Nephrol. 2012. PMID: 22506110 Free PMC article.
-
How to make it in the urinary tract: a tutorial by Escherichia coli.PLoS Pathog. 2012;8(10):e1002907. doi: 10.1371/journal.ppat.1002907. Epub 2012 Oct 4. PLoS Pathog. 2012. PMID: 23055921 Free PMC article. Review. No abstract available.
-
Effects of sub-minimum inhibitory concentrations of ciprofloxacin on biofilm formation and virulence factors of Escherichia coli.Braz J Infect Dis. 2019 Jan-Feb;23(1):15-21. doi: 10.1016/j.bjid.2019.01.004. Epub 2019 Feb 21. Braz J Infect Dis. 2019. PMID: 30796889 Free PMC article.
References
-
- Janeway CA, Travers P, Walport M, Capra JD. The Immune System in Health and Disease. 4. New York: Garland; 1999. Immunobiology.
-
- Osterlund A, Engstrand L. Intracellular penetration and survival of Streptococcus pyogenes in respiratory epithelial cells in vitro. Acta Otolaryngol. 1995;115:685–688. - PubMed
-
- Petersen AM, Krogfelt KA. Helicobacter pylori: an invading micro-organism? A review FEMS. Immunol Med Microbiol. 2003;36:117–126. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical